🔎 Trials Near Me

Почетна › Карцином на јајниците › Мисури

Клинички испитувања за Карцином на јајниците во Мисури

41 студии за Карцином на јајниците бараат учесници на локации во Мисури.

Градови во Мисури

Официјален текст на студијата (англиски)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Saint Luke's Hospital of Kansas City, Kansas City
  • Washington University School of Medicine, St Louis
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • Washington University School of Medicine in St. Louis, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 5.10.2026 · NCT06915025

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • и уште 2
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Saint Francis Medical Center, Cape Girardeau
  • Saint Luke's Hospital, Chesterfield
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • и уште 13
Се регрутираФаза 2
Сите возрасти · Сите полови · Ажурирано 5.10.2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Washington University Medicine, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Washington University School of Medicine in St. Louis, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06172478

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

  • WU St Louis, St Louis
Се регрутира
Возраст 18 и постари · Жени · Ажурирано 29.9.2026 · NCT05287451

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  • Washington University, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT06799065

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • Cox Medical Center South /ID# 274826, Springfield
  • Mercy David C. Pratt Cancer Center /ID# 275655, St Louis
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 29.9.2026 · NCT06890338

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Washington University, St Louis
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT04981119

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • University of Missouri Hospital, Columbia
  • HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
  • Cox Medical Center North, Springfield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Washington University School of Medicine in St. Louis, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213791

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Washington Univ. School of Medicine, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07109726

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Mercy Hospital St. Louis - David C. Pratt Cancer Center, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 15.9.2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Washington University, St Louis
Се регрутираФаза 2
Возраст од 18 до 99 · Жени · Ажурирано 15.9.2026 · NCT07023627

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT05123482

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • Washington University School of Medicine ( Site 0052), St Louis
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 3.9.2026 · NCT06824467

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

  • Washington University School of Medicine, St Louis
  • Mercy Hospital St. Louis, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 26.8.2026 · NCT05281471

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Washington University School of Medicine, St Louis
Се регрутираФаза 1/2
12 Months – 30 Years · Сите полови · Ажурирано 25.8.2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Washington University, Siteman Cancer Center, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT06774963

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07182149

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Mercy Hospital Springfield, Springfield
  • Washington University School of Medicine, St Louis
  • Missouri Baptist Medical Center, St Louis
Се регрутира
Возраст од 35 до 50 · Жени · Ажурирано 7.8.2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • и уште 20
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 7.8.2026 · NCT06580314

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT06910657

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Washington University, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Washington University School of Medicine Obstetrics and Gynecology, St Louis
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 28.7.2026 · NCT06161025

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph
Се регрутираФаза 2
Возраст 8 и постари · Сите полови · Ажурирано 27.7.2026 · NCT05503797

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #110, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.7.2026 · NCT06545942

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 334, Kansas City
  • 521, St Louis
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 16.7.2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Saint Luke's Cancer Institute, Kansas City
  • Washington University, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 7.7.2026 · NCT05768139

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • Saint Louis University, St Louis
Се регрутираФаза 1/2
Возраст од 18 до 90 · Сите полови · Ажурирано 6.7.2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • и уште 3
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 19 до 110 · Сите полови · Ажурирано 29.6.2026 · NCT02012699

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

  • Washington University, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 12.6.2026 · NCT06051695

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

  • Washington University School of Medicine in St. Louis, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Жени · Ажурирано 28.5.2026 · NCT06930755

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

  • Research site, St Louis
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06386146

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center North, Kansas City
  • University of Kansas Cancer Center Lee's Summit, Lee's Summit
  • и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 16.4.2026 · NCT05659381

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

  • Site 0111, St Louis
Се регрутираФаза 1
Возраст 18 и постари · Жени · Ажурирано 7.4.2026 · NCT04516447

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

  • Washington University Medical Center, St Louis
Се регрутира
Возраст од 25 до 50 · Жени · Ажурирано 6.4.2026 · NCT04294927

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  • Washington University, St Louis
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 23.12.2025 · NCT06690775

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.